Design and rationale of a pragmatic trial integrating routine screening for atrial fibrillation at primary care visits: The VITAL-AF trial

Authors:

Abstract
No abstract available
Funding Information
  • National Institutes of Health (NSF-12-512)
  • Samsung
  • National Heart, Lung, and Blood Institute
  • Medtronic
  • American Heart Association (18SFRN34110082)
  • National Center for Complementary and Integrative Health
  • Boehringer Ingelheim
  • Johnson and Johnson
  • National Science Foundation (1RO1HL092577, K24HL105780, R01HL128914)
  • Merck
  • Pfizer
  • Biotronik
  • Philips
  • Bayer
  • Broad Institute
  • Abbott Laboratories
  • Quest Diagnostics
  • Bristol-Myers Squibb
  • Fondation Leducq (14CVD01, 18SFRN34250007, 1R01HL139731)

This publication has 40 references indexed in Scilit: